Cargando…
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
IDH1 mutations frequently occur early in human glioma. While IDH1 mutation has been shown to promote gliomagenesis via DNA and histone methylation, little is known regarding its regulation in antiviral immunity. Here, we discover that IDH1 mutation inhibits virus-induced interferon (IFN) antiviral r...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600173/ https://www.ncbi.nlm.nih.gov/pubmed/37880243 http://dx.doi.org/10.1038/s41467-023-42545-3 |
_version_ | 1785125931749212160 |
---|---|
author | Chen, Xueqin Liu, Jun Li, Yuqin Zeng, Yuequan Wang, Fang Cheng, Zexiong Duan, Hao Pan, Guopeng Yang, Shangqi Chen, Yuling Li, Qing Shen, Xi Li, Ying Qin, Zixi Chen, Jiahong Huang, Youwei Wang, Xiangyu Lu, Yuli Shu, Minfeng Zhang, Yubo Wang, Guocai Li, Kai Lin, Xi Xing, Fan Zhang, Haipeng |
author_facet | Chen, Xueqin Liu, Jun Li, Yuqin Zeng, Yuequan Wang, Fang Cheng, Zexiong Duan, Hao Pan, Guopeng Yang, Shangqi Chen, Yuling Li, Qing Shen, Xi Li, Ying Qin, Zixi Chen, Jiahong Huang, Youwei Wang, Xiangyu Lu, Yuli Shu, Minfeng Zhang, Yubo Wang, Guocai Li, Kai Lin, Xi Xing, Fan Zhang, Haipeng |
author_sort | Chen, Xueqin |
collection | PubMed |
description | IDH1 mutations frequently occur early in human glioma. While IDH1 mutation has been shown to promote gliomagenesis via DNA and histone methylation, little is known regarding its regulation in antiviral immunity. Here, we discover that IDH1 mutation inhibits virus-induced interferon (IFN) antiviral responses in glioma cells. Mechanistically, D2HG produced by mutant IDH1 enhances the binding of DNMT1 to IRF3/7 promoters such that IRF3/7 are downregulated, leading to impaired type I IFN response in glioma cells, which enhances the susceptibility of gliomas to viral infection. Furthermore, we identify DNMT1 as a potential biomarker predicting which IDH1mut gliomas are most likely to respond to oncolytic virus. Finally, both D2HG and ectopic mutant IDH1 can potentiate the replication and oncolytic efficacy of VSVΔ51 in female mouse models. These findings reveal a pivotal role for IDH1 mutation in regulating antiviral response and demonstrate that IDH1 mutation confers sensitivity to oncolytic virotherapy. |
format | Online Article Text |
id | pubmed-10600173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106001732023-10-27 IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma Chen, Xueqin Liu, Jun Li, Yuqin Zeng, Yuequan Wang, Fang Cheng, Zexiong Duan, Hao Pan, Guopeng Yang, Shangqi Chen, Yuling Li, Qing Shen, Xi Li, Ying Qin, Zixi Chen, Jiahong Huang, Youwei Wang, Xiangyu Lu, Yuli Shu, Minfeng Zhang, Yubo Wang, Guocai Li, Kai Lin, Xi Xing, Fan Zhang, Haipeng Nat Commun Article IDH1 mutations frequently occur early in human glioma. While IDH1 mutation has been shown to promote gliomagenesis via DNA and histone methylation, little is known regarding its regulation in antiviral immunity. Here, we discover that IDH1 mutation inhibits virus-induced interferon (IFN) antiviral responses in glioma cells. Mechanistically, D2HG produced by mutant IDH1 enhances the binding of DNMT1 to IRF3/7 promoters such that IRF3/7 are downregulated, leading to impaired type I IFN response in glioma cells, which enhances the susceptibility of gliomas to viral infection. Furthermore, we identify DNMT1 as a potential biomarker predicting which IDH1mut gliomas are most likely to respond to oncolytic virus. Finally, both D2HG and ectopic mutant IDH1 can potentiate the replication and oncolytic efficacy of VSVΔ51 in female mouse models. These findings reveal a pivotal role for IDH1 mutation in regulating antiviral response and demonstrate that IDH1 mutation confers sensitivity to oncolytic virotherapy. Nature Publishing Group UK 2023-10-25 /pmc/articles/PMC10600173/ /pubmed/37880243 http://dx.doi.org/10.1038/s41467-023-42545-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Chen, Xueqin Liu, Jun Li, Yuqin Zeng, Yuequan Wang, Fang Cheng, Zexiong Duan, Hao Pan, Guopeng Yang, Shangqi Chen, Yuling Li, Qing Shen, Xi Li, Ying Qin, Zixi Chen, Jiahong Huang, Youwei Wang, Xiangyu Lu, Yuli Shu, Minfeng Zhang, Yubo Wang, Guocai Li, Kai Lin, Xi Xing, Fan Zhang, Haipeng IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title_full | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title_fullStr | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title_full_unstemmed | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title_short | IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
title_sort | idh1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600173/ https://www.ncbi.nlm.nih.gov/pubmed/37880243 http://dx.doi.org/10.1038/s41467-023-42545-3 |
work_keys_str_mv | AT chenxueqin idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT liujun idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT liyuqin idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT zengyuequan idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT wangfang idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT chengzexiong idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT duanhao idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT panguopeng idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT yangshangqi idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT chenyuling idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT liqing idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT shenxi idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT liying idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT qinzixi idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT chenjiahong idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT huangyouwei idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT wangxiangyu idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT luyuli idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT shuminfeng idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT zhangyubo idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT wangguocai idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT likai idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT linxi idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT xingfan idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma AT zhanghaipeng idh1mutationimpairsantiviralresponseandpotentiatesoncolyticvirotherapyinglioma |